|
Volumn 2, Issue 2, 2012, Pages 115-116
|
New roles opined for OPCML
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CELL ADHESION MOLECULE;
EPHRIN RECEPTOR A2;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FIBROBLAST GROWTH FACTOR RECEPTOR;
FIBROBLAST GROWTH FACTOR RECEPTOR 1;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
OPIOID BINDING PROTEIN CELL ADHESION MOLECULE;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE B;
PROTEIN TYROSINE KINASE;
RECOMBINANT OPIOID BINDING PROTEIN CELL ADHESION MOLECULE;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER INHIBITION;
CELL DEATH;
COMPUTER MODEL;
DOWN REGULATION;
HUMAN;
NONHUMAN;
OVARY CANCER;
PROTEIN PROTEIN INTERACTION;
TUMOR VOLUME;
ANIMALS;
CELL ADHESION MOLECULES;
FEMALE;
GPI-LINKED PROTEINS;
HUMANS;
NEOPLASMS, GLANDULAR AND EPITHELIAL;
OVARIAN NEOPLASMS;
RECEPTOR PROTEIN-TYROSINE KINASES;
|
EID: 84865719776
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-11-0356 Document Type: Article |
Times cited : (10)
|
References (8)
|